Kesso-Mycin en es it fr

Kesso-Mycin Brand names, Kesso-Mycin Analogs

Kesso-Mycin Brand Names Mixture

  • No information avaliable

Kesso-Mycin Chemical_Formula


Kesso-Mycin RX_link

No information avaliable

Kesso-Mycin fda sheet

Kesso-Mycin msds (material safety sheet)

Kesso-Mycin Synthesis Reference

No information avaliable

Kesso-Mycin Molecular Weight

167.205 g/mol

Kesso-Mycin Melting Point

96 oC

Kesso-Mycin H2O Solubility

2500 mg/L

Kesso-Mycin State


Kesso-Mycin LogP


Kesso-Mycin Dosage Forms

No information avaliable

Kesso-Mycin Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

Kesso-Mycin Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

Kesso-Mycin Absorption

Rapidly absorbed following oral administration.

Kesso-Mycin side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

Kesso-Mycin Patient Information

Kesso-Mycin Organisms Affected

Humans and other mammals